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Abstract 
Protecting astronauts from space radiation exposure is an important challenge for mission 
design and operations for future exploration-class and long-duration missions.  Crew 
members are exposed to sporadic solar particle events (SPEs) as well as to the continuous 
galactic cosmic radiation (GCR).  If sufficient protection is not provided the radiation risk 
to crew members from SPEs could be significant.  To improve exposure risk estimates 
and radiation protection from SPEs, detailed variations of radiation shielding properties 
are required.  A model using a modern CAD tool ProE™, which is the leading 
engineering design platform at NASA, has been developed for this purpose.  For the 
calculation of radiation exposure at a specific site, the cosine distribution was 
implemented to replicate the omnidirectional characteristic of the 4π particle flux on a 
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surface.  Previously, estimates of doses to the blood forming organs (BFO) from SPEs 
have been made using an average body-shielding distribution for the bone marrow based 
on the computerized anatomical man model (CAM).  The development of an 82-point 
body-shielding distribution at BFOs made it possible to estimate the mean and variance 
of SPE doses in the major active marrow regions.  Using the detailed distribution of bone 
marrow sites and implementation of cosine distribution of particle flux is shown to 
provide improved estimates of acute and cancer risks from SPEs. 
 
1. Introduction 
 
NASA follows radiation exposure limits (Cucinotta and Durante 2006) and 
implements appropriate risk mitigation measures to ensure that humans can safely live 
and work in the space radiation environment anywhere, anytime.  In the context of the 
radiation protection principle of “as low as reasonably achievable” (ALARA), “safely” 
means that acceptable risks are not exceeded during crew members’ lifetimes, where 
“acceptable risks” include limits on post-mission and multi-mission consequences.  In 
design of future space missions and for the implementation of health protection measures, 
accurate predictions of astronaut’s radiation exposure are required.   In the simulation of 
lunar radiation interactions of large SPEs, radiation transport properties of shielding 
materials and astronaut’s body tissues were calculated by the BRYNTRN code system 
(Cucinotta et al. 1994).  In the previous work for future space mission design (Kim et al. 
2005), a typical shield configuration has been approximated as a spherical structure and 
one of sensitive sites of blood-forming organ (BFO) was taken as an average body-
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shielding distribution of the bone marrow using the computerized anatomical man 
(CAM) model based on the astronaut body geometry (Billings and Yucker 1973).  With 
these approximations, the overall exposure levels at the sensitive sites were reduced to 
within the current exposure limits from a large SPE by adding effective polyethylene 
shielding to various spacecraft thicknesses.     
 
In the development of an integrated strategy to provide astronauts maximal 
radiation protection with consideration of the mass constraints of space missions, the 
focus of the current work was to provide several considerations in detail for the 
improvement of risk assessment.  Detailed variations of radiation shielding properties 
were modeled using a modern CAD tool ProE™ (2004), representing a significant 
improvement in shielding analysis because it provides an analysis tool on the identical 
platform of most engineering designs of space vehicles.  Another consideration includes 
the correctly aligned geometries between human and vehicle at a specific exposure site 
and the correction of particle source to replicate the omnidirectional characteristic of the 
4π particle flux on a surface.  Because the specific doses at various BFOs account for the 
considerable variations of proton fluences across marrow regions, an 82-point body-
shielding distribution at BFOs was developed and the mean and variance of SPE doses 
were made with detailed distributions of major active marrow regions of head and neck, 
chest, abdomen, pelvis, and thighs.  
 
The current considerations are among many requirements that must be met to 
improve the estimation of effective doses for radiation cancer risks.  By implementing the 
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distribution of shielding properties, detailed directional risk assessment was visualized, 
which can guide the ultimate protection for risk mitigation inside a habitable volume 
during future exploration missions.   
 
2.  Approach of Risk Assessment 
 
Space radiation is a large health concern for astronauts who are involved in space 
missions outside the Earth’s geomagnetic field.  In addition to the continuous background 
exposure to GCR, sporadic exposure to SPEs present the most significant risk for short-
stay lunar missions (<90 d).  The risk of early effects is very small due to the reduction of 
dose-rates behind shielding (<1 cGy/h) (Cucinotta and Durante 2006), however radiation 
sickness is a concern for extra-vehicular activities (EVAs) on the moon where shielding 
will be at a minimum.  The physical compositions and intensities of historically large 
SPEs are routinely examined in sensitive astronaut tissues behind various shielding 
materials using the Baryon transport code, BRYNTRN (Cucinotta et al., 1994), to predict 
the propagation and interactions of the deep-space nucleons through various media.  The 
radiation risk at the sensitive tissue sites and the effective dose were assessed with the 
transported properties of the shielding materials and the astronauts’ body tissue.  The 
representative shield configurations were assumed to be aluminum with spherical 
thickness for spacesuit and spacecraft.  Body-shielding distributions at sensitive organ 
sites of astronaut surrounding a specific point were generated using the CAM model 
(Billings and Yucker, 1973).  The point particle fluxes that are traversed the tissue 
equivalent material of water for 512 rays were calculated at a specific anatomical area 
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inside a shield.  Assessment of radiation risk at a specific organ or tissue was calculated 
with the point particle fluxes.  The effective dose (E), which is currently used for NASA  
operational radiation protection program, is the representative quantity of stochastic 
effects for human body, where the radiation quantities of individual organs or tissues are 
multiplied by their respective tissue weighting factors (ICRP60, NCRP116).  Figure 1 
shows the exposure levels in free space as a function of shielding thickness of a spherical 
configuration for aluminum and graphite from August 1972 SPE (King 1972).  
  
Structural design and variations of material composition layers have been 
considered for the total integrated shielding calculations by utilizing CAMERA ray-
tracing algorithm at several dose measurement locations for space shuttle and 
International Space Station lab module (Saganti et al. 2001).  At each dose location, 
evenly spaced distributions of 512 rays over a 4 π solid angle were used for the point flux 
calculation of a given ambient radiation.  In Table 1, the exposure estimates obtained 
from the ray-tracing are compared with the values at the average shielding thickness of 
each dosimetry locations (DLOCs) of space shuttle from August 1972 SPE.  The latter 
values are taken from the spherical configuration in the Figure 1.  It surely shows the big 
difference.  The improved exposure estimates were made after accounting for the 
structural configuration by utilizing ray-tracing.   
 
Table 1.  Comparison of exposure estimates of ray-tracing with those at the average 
thickness of the 6 dosimetry locations of shuttle from August 1972 SPE. 
Shuttle Effective dose, cSv BFO dose at the average 
BFO site, cGy-Eq 
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dosimetry 
location ∑= iXNX 1 )(1 iXENE ∑= )(1 iXBNB ∑=)(XE )(XB  , , ,   
Average 
shielding 
thickness, g/cm
With ray- tracing With ray- tracing 
2
DLOC1 26.67 36.41 2.8 24.28 1.8 
DLOC2 16.46 76.05 8.0 49.62 7.0 
DLOC3 19.44 72.60 4.5 47.13 3.5 
DLOC4 20.01 60.11 4.4 41.77 3.4 
DLOC5 21.08 73.44 3.9 48.10 3.0 
DLOC6 20.92 74.09 3.9 48.96 3.0 
  
 
3.  Structural Distribution Model Using ProE™ 
Recognizing that polymeric materials have better shielding effectiveness with 
reduced mass constraint (Wilson et al. 1995), future exploratory-class spacecraft will be 
composed with various high-performance polymeric composites with enhanced 
material’s property and multi-functionalities, while the basic spacecraft construction 
material has been aluminum.  Since the low-energy proton spectra are attenuated rapidly 
with shielding, the important factors for determining the exposure levels at sensitive 
tissue sites are the mass distributions of the detailed structural shielding materials and the 
astronaut’s body.  
 
 To quantify each directional shielding amount offered by material composition 
layers, a structural distribution model was developed to account for detailed spacecraft 
geometry by using CAD tool of ProE™ (2004).  All of structural components and 
contents, such as various racks, equipments, and inner and outer shell materials of the 
exploratory-class spacecraft, were included into the model with the detailed 
atomic/molecular compositions, their bulk densities, and the linear dimensions for the 
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ray-tracing calculation.  Each ray evaluates the directional distribution of material 
intersections for space radiation propagation to a specific interior dosimetry evaluation 
point.  Using the characteristic of shield property, which depends on the basic 
atomic/molecular and nuclear processes, the complexity of vector rays with actual 
materials is equated to the vector rays of a specified common spacecraft material, e.g. 
aluminum-equivalent, according to the following equation:  
)()( 50
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TT ××=×=− ρ )()( pRpR     (1) 
Where  
T :  Areal density of aluminum-equivalent, in g/cm2Al-eq
TMat:   Areal density of a material, in g/cm2
XMat:  Linear thickness of a material, in cm 
RAl(p ):  Range of 50 MeV proton beam on aluminum, in g/cm250 MeV
RMat(p ):  Range of 50 MeV proton beam on a target material, in g/cm250 MeV
rMat:  Bulk density of a material , in g/cm3
A new fully automated method uses complete list of actual materials for selection 
and allows the ray-tracings for the equivalent thickness of any given material at the user-
specific dosimetry points for the evaluation of shielding.  Figure 2 shows an example of 
the structural distribution model developed using ProE™.  Figure 3 shows the integrated 
shielding thickness distributions at 4 different dosimetry locations obtained from this 
model.  It surely shows inherent directional variation of shielding thickness by which hot 
spot can be easily pointed out in a habitable volume.   
 
4.  Radiation Source Consideration 
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For the principal goal of planetary radiation simulation at a critical site of human 
body inside a spacecraft, habitat, or spacesuit during EVA on lunar or Mars surface, the 
production of emitted ion spectra was predicted by solving the fundamental Boltzmann 
transport equation for the propagation and interaction of the deep-space nucleons and 
heavy ions through various media.  The fully coupled, all energy, all particle simulation 
was made for given number of rays by using the new fully automated ray tracing model, 
in which detailed radiation shielding properties were fully accounted for each ray with 
each separate medium’s thickness distribution along a ray surrounding at a specific 
position.  Similarly, radiation point flux at a specific organ site was calculated with 
detailed body-shielding properties at the site of human body geometry using the CAM 
model based on the 50 percentile United States Air Force male in the standing position 
(Billings and Yucker, 1973). 
 
When it comes to the angular description of incident particle on a specific 
location, until now it has been treated as an isotropic angular distribution: 
         (2) constant)( =μp
where μ is the cosine of the angle between the particle direction (the ray) and the surface 
normal (on the surface of a specific organ site).  It is a common mistake to give the 
incident particles an isotropic angular distribution in an attempt to replicate the 
omnidirectional characteristic of a 4 π point flux.  The appropriate method for describing 
a surface source of particles incident on a specific organ site is actually a cosine 
distribution: 
μμ =)(p           (3) 
 8
  
for a uniformly distributed source of particles at the site.  In this way, energy deposited 
into the small volume site of an organ is correctly accounted for all the incident particles 
which are evenly spaced for the given number of rays over a 4π solid angle. 
The shielding distribution can be treated as randomly oriented for spacecraft and 
body organs or as a fixed alignment when evaluating organ doses inside spacecraft.  
Either case is an idealization of the actual motion of an astronaut inside a spacecraft or 
habitat.  For the latter case, the fully coupled shielding properties at each direction 
between the integrated shielding by spacecraft and the body-shielding were correctly 
obtained only after their orientations were correctly aligned at a specific organ site.  The 
improved organ dose assessment at a specific anatomical location was estimated with the 
correct point particle fluxes for given number of rays and the correctly coupled shielding 
thickness at each rays: 
 
5.  Consideration of Active Bone Marrow Distributions 
The most critical organ site considered for radiation protection is BFO.  It has 
been assumed as an average body-shielding distribution for the bone marrow based on 
CAM model.  However, quantitative estimates of the active bone marrow in adults are 
quite distributed over several body regions as shown in Table 2 (Cristy, 1981).  
Therefore, the 82 specific BFO sites of the different active regions as shown in Figure 4 
were accounted for the human body geometry using the CAM model (Atwell, 1994).  
Estimates of specific dose at various BFO sites have been shown large variations inside a 
typical equipment room of spacecraft (an aluminum sphere of 5 g/cm2 thickness) on lunar 
surface as shown in figure 5.  The fact that considerable variance of doses across marrow 
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sites was caused by the characteristic spectra of proton fluence at each site made the use 
of an average BFO doubtful.  The variations will be further increased when the 
complexities of spacecraft distributions will be accounted, which is necessary for the 
accurate radiation risk assessment prediction and protection guide from the complex 
radiation fields and shielding distributions.  The development of the 82-point BFO 
shielding distribution made it possible to estimate the mean and variance of SPE doses in 
the major active marrow regions of head and neck, chest, abdomen, pelvis, and thighs as 
shown in Figure 6.  It will allow more accurate estimates of the marrow response to 
estimate the radiation risk of leukemia, which could be the dominant risk to astronauts 
from a major SPE (Cucinotta et al. 2006). 
Table 2.  Active marrow distributions in adults (age 40) calculated from anatomical 
data (Cristy, 1981) 
Body region  Marrow  distribution 
Head and Neck 12.2% 
Chest (Upper Torso) 26.1% 
Abdomen (Mid Torso) 24.9% 
Pelvis (Lower Torso) 33.4% 
Thighs (Upper Legs) 3.4% 
Lower Legs n/a 
Arms n/a 
 
6.  Results and discussion 
 For use in the effort to make accurate assessment of radiation doses to astronauts, 
which are required for planning of future exploration-class and long-duration space  
missions (Cucinotta and Durante 2006), a fully automated structural distribution model 
has been developed using a CAD tool of ProE™.  Visual presentation of shielding 
thickness easily shows that the hot spots are existed for sensitive sites of tissue/organ 
inside a future spacecraft, while its overall configuration provides enough shielding from 
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a SPE as shown in figure 3.  With the directional shielding amounts, the results of organ 
dose quantities are shown in Table 3 at four different locations inside a spacecraft.  We 
also implemented radiation source corrections: (1) cosine distribution for the angular 
description of incident particle on a specific site and (2) correct alignment of spacecraft 
and body for the coupled shielding properties for each rays.  The results are shown in the 
same table in the column labeled as ‘Aligned orientation’.   Finally, detailed directional 
risk assessment is visualized in figure 7 at a dosimetry location (DLOC1) inside a 
spacecraft.  In this figure, the spacecraft is shown in a translucent view to reveal the exact 
dosimetry location in the left hand side, and the same directional dose assessment is 
separately shown in large view in the right hand side.  This kind of visualization can 
guide the ultimate protection for risk mitigation inside a habitable volume during future 
exploration missions.  It is easily noticed that top hatch of a spacecraft can provide the 
most shielding effect from SPE, while some area like window is the least.  This rationale 
will help to develop many objective-oriented strategies, such as local shielding 
approaches, optimization of equipments/components as shields, and optimization of 
astronaut orientation. 
 
  Because of the characteristic spectra of primary solar protons of SPE, proton 
fluences and doses vary considerably across marrow regions.  Detailed body-shielding 
distribution of 82 bone marrow sites were accounted for the active marrow regions, 
which faithfully reproduced the mean and the standard deviations of SPE doses in those 
regions.  More accurate estimates of the marrow response will be used to estimate the 
radiation risk of leukemia from a major SPE (Cucinotta et al. 2006).  The large variation 
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in marrow doses has opposite results when considering acute risks versus the risk of 
leukemia.  For the acute risk to the BFOs, the marrow with lower dose component is fully 
capable of replenishing the entire blood system.  Therefore, knowledge of the variation is 
extremely important.  For leukemia risk, a linear-quadratic dose response is found (NCRP 
132).  Therefore, the marrow regions with high doses are the concern since leukemia risk 
may arise from a large SPE condition where the quadratic component of the dose-
response comes into play.  
 
 In the current work, we made significant improvement of risk assessment with the 
several considerations.  Many other requirements must be improved as future work for 
the risk assessment and protection of astronauts, which may include new definition of age 
and gender related tissue weighting factors, modified transport codes with neutrons 
produced inside spacecraft, improved space environmental projection models for mission 
planning, and using all detailed transport properties with the atomic properties of 
structural components by using parallel processing. 
 
Table 3.  Result of organ dose quantities by using the fully automated structural 
distribution model, and comparison with results from implementing radiation source 
correction at each ray (aligned orientation).  
August 1972 SPE 
  Random orientation Aligned orientation 
DLOC1 DLOC2 DLOC3DLOC4DLOC1DLOC2 DLOC3 DLOC4
X-coordinate, cm 43.18 -43.18 40.64 -40.64 43.18 -43.18 40.64 -40.64 
Y-coordinate, cm 119.38 119.38 119.38 119.38 119.38 
Z-coordinate, cm 52.71 52.71 -79.34 -79.34 52.71 
119.38 119.38 119.38 
52.71 -79.38 -79.38 
Al-Eq xavg, g/cm2 15.18 15.08 15.85 15.33 15.18 15.08 15.85 15.33 
x  - x 0 - 0 - 0 – 0 - 0 - 0 - 0 – 0 - min max
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102.07 105.50 83.21 85.79 102.07 105.50 83.21 85.79 
Avg skin      126.61 121.07 104.08 108.59 150.92 135.41 111.45 114.45 
Eye           86.76 84.36 73.58 77.06 89.71 89.94 81.62 79.72 
Avg BFO       16.91 16.82 15.2 15.88 18.14 18.20 16.05 15.98 
Stomach      7.38 7.37 6.77 7.03 6.94 6.89 6.59 6.63 
Colon        14.42 14.36 13.04 13.6 14.46 14.36 12.67 12.79 
Liver        10.37 10.33 9.41 9.8 9.43 9.60 8.92 9.23 CAM 
organ 
dose, 
cSv 
Lung         12.16 12.12 11.04 11.5 12.09 11.61 11.30 10.73 
Esophagus   11.61 11.57 10.54 10.98 11.25 10.78 10.52 9.93 
Bladder    7.54 7.53 6.9 7.17 7.64 7.25 6.98 6.84 
Thyroid    18.39 18.31 16.55 17.28 18.55 18.15 16.47 16.79 
Chest             72.23 70.58 61.85 64.83 74.88 73.95 67.60 66.37 
Gonads       35.27 34.74 30.76 32.24 37.72 32.64 31.19 27.74 
Front brain 29.54 29.32 26.31 27.53 28.72 27.60 25.32 25.32 
Mid brain 16.2 16.15 14.68 15.3 15.52 15.56 14.05 15.03 
Rear brain 28.93 28.72 25.79 26.98 27.49 27.96 24.98 27.84 
Point dose eq, cSv 254.68 242.74 207.92 216.83 253.48 241.76 205.76 211.88 
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Figure 1.  Effective dose and BFO dose behind aluminum and graphite shielding 
materials in free space from August 1972 solar particle event. 
  
Figure 2.  Structural distribution model of various composition layers for exploratory-
class spacecraft developed using ProE™. 
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Figure 3.  Shielding distributions at 4 different locations inside a spacecraft. 
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Figure 4.  The 82-point BFO sites to cover the different active marrow regions.
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Figure 5.  Absorbed dose distributions at 82 BFO sites of astronaut inside a typical 
equipment room of spacecraft on lunar surface from August 1972 SPE.   
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Figure 6.  The average BFO doses and their standard deviations from August 1972 SPE 
for various body regions of active marrow sites located at 6 dosimetry locations (DLOCs) 
of space shuttle. 
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Figure 7.  Visualization of detailed directional dose assessment at a dosimetry location 
(DLOC1) inside a spacecraft.  The spacecraft is shown in a translucent view to reveal the 
exact dosimetry location (left), and the same directional dose assessment is separately 
shown in large view (right).  
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Tissue or Organ Tissue Weighting Factor, wT 
Gonads 0.2 
Bone Marrow (red) 0.12 
Colon 0.12 
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Bladder 0.05 
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Liver 0.05 
Esophagus 0.05 
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Bone Surface 0.01 
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Risk Assessment and Protection 
 Accurate shielding distributions of space vehicle and 
human body organs
 Correctly aligned geometries between human and vehicle    
 Detailed distribution of bone marrow sites
9 Head and neck, chest, abdomen, pelvis, and thighs
9 Age dependence of the sites
⇒ Visualization of risk with directional contribution provides
ultimate protection for astronauts in a habitable volume.
2007-01-3116
Aluminum Equivalent Thickness
for
Detailed Spacecraft Components
)50(
)50(
)50(
)50(
MeVR
MeVRX
MeVR
MeVRTT
Mat
Al
MatMat
Mat
Al
MateqAl ××=×=− ρ
Where,
TAl-eq: Areal density of aluminum equivalent, g/cm2
TMat: Areal density of a material, g/cm2
XMat: Lineal thickness of a material, cm
RAl(50 MeV): Range of 50 MeV proton beam on aluminum, g/cm2
RMat(50 MeV): Range of 50 MeV proton beam on a target material, g/cm2ρMat: Bulk density of a material , g/cm3
2007-01-3116
Structural Distribution Model Using ProE™
Various Composition Layers 
for Exploratory-Class Spacecraft
2007-01-3116
Structural Distribution Model Using ProE™
Various Composition Layers 
for Exploratory-Class Spacecraft
2007-01-3116
Ray Tracings at 4 DLOCs inside Spacecraft 
2007-01-3116
Shielding Distributions at 4 DLOCs of Spacecraft
2007-01-3116
Random Orientation
• Discrete number of evenly 
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rays
• Cosine angular distribution in a 
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N: the given number of rays
Xi: a shielding amount by material 
composition layers at ith ray
Aligned Orientation
where, 
θ: polar angle of a ray
φ: azimuth angle of a ray
X(θ,φ):  the integrated shielding 
thickness by spacecraft of a ray
Y(θ,φ):  the body-shielding thickness 
of a ray   
∑
=
=
N
i
iorganorgan XHN
H
1
)(1 ( )
Idealization of the Actual Motion of Astronauts
∫ ∫
−=
+= 2
2
),(),(cos
π
πθ
φθφθφθθ YXHddHorgan
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Dose Distributions
at 4 DLOCs inside Spacecraft
from 1972 SPE
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2007-01-3116
August 1972 SPE
Random Orientation Aligned Orientation
DLOC1 DLOC2 DLOC3 DLOC4 DLOC1 DLOC2 DLOC3 DLOC4
X-coordinate, cm
Y-coordinate, cm
Z-coordinate ,cm
43.18
119.38
52.71
-43.18
119.38
52.71
40.64
119.38
-79.34
-40.64
119.38
-79.34
43.18
119.38
52.71
-43.18
119.38
52.71
40.64
119.38
-79.38
-40.64
119.38
-79.38
Al-Eq Xave, g/cm2 15.18 15.08 15.85 15.33 15.18 15.08 15.85 15.33
X_min - X_max
0 -
102.07 0 - 105.50 0 – 83.21 0 - 85.79 0 - 102.07 0 - 105.50 0 – 83.21 0 - 85.79
AVG SKIN     126.61 121.07 104.08 108.59 150.92 135.41 111.45 114.45
EYE          86.76 84.36 73.58 77.06 89.71 89.94 81.62 79.72
AVG BFO      16.91 16.82 15.2 15.88 18.14 18.20 16.05 15.98
STOMACH     7.38 7.37 6.77 7.03 6.94 6.89 6.59 6.63
COLON       14.42 14.36 13.04 13.6 14.46 14.36 12.67 12.79
LIVER       10.37 10.33 9.41 9.8 9.43 9.60 8.92 9.23
LUNG        12.16 12.12 11.04 11.5 12.09 11.61 11.30 10.73
OESOPHAGUS  11.61 11.57 10.54 10.98 11.25 10.78 10.52 9.93
BLADDER     7.54 7.53 6.9 7.17 7.64 7.25 6.98 6.84
THYROID    18.39 18.31 16.55 17.28 18.55 18.15 16.47 16.79
CHEST            72.23 70.58 61.85 64.83 74.88 73.95 67.60 66.37
GONADS      35.27 34.74 30.76 32.24 37.72 32.64 31.19 27.74
FRONT BRAIN 29.54 29.32 26.31 27.53 28.72 27.60 25.32 25.32
MID BRAIN 16.2 16.15 14.68 15.3 15.52 15.56 14.05 15.03
REAR BRAIN 28.93 28.72 25.79 26.98 27.49 27.96 24.98 27.84
Point dose eq, cSv 254.68 242.74 207.92 216.83 253.48 241.76 205.76 211.88
CAM 
organ 
dose, 
cSv
Organ Dose Quantities with Ray Tracing
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82 BFO Locations
● 32-location set
● 50-location set
x
y
z
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Body Regions for BFO Locations 
and 
Active Marrow Distributions in Adult (Cristy, 1981) 
Region Number Body Region Location Marrow  Distribution
1 Head and Neck Z= up to 11.34" 12.2%
2 Chest (Upper Torso) Z=11.34" to 15.6" 26.1%
3 Abdomen (Mid Torso) Z=15.6" to 27.0" 24.9%
4 Pelvis (Lower Torso) Z=27.0" to 36.7" 33.4%
5 Thighs (Upper Legs) Z=36.7" to 52.3" 3.4%
6 Lower Legs Z=52.3" to 70" n/a
7 Arms Y<-6.9" for right arm; 
Y>6.9" for left arm
n/a
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BFO Dose from August 1972 SPE at DLOC1
0
20
40
60
80
100
120
140
160
BFO site
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Head & neck        Chest                         Abdomen        Pelvis              Thighs   
Lower legs    Arms
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Concluding Remarks
 Accurate shielding distributions are obtained from SRP 
(Space Radiation Program) ray tracer and geometries 
between human and vehicle are correctly aligned:
¾ There are still hot spots for sensitive site of tissue/organ 
inside a spacecraft with overall thick enough shielding 
configuration. 
 Detailed distribution of bone marrow sites are considered: 
¾ Head and neck, chest, abdomen, pelvis, and thighs
⇒ Detailed distribution of directional risk assessment can
guide the ultimate protection for risk mitigation inside 
a habitable volume during future exploration missions.
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 Age- and gender-related tissue weighting factors must 
be defined.
 Modified transport codes are needed with vehicle-
produced secondary neutrons.
 Improved environmental projection model is needed for 
mission planning.
 Transport properties with their atomic properties should be
accounted for each detailed structural components (parallel
processing).
 Local shielding approaches including astronaut orientation
optimization will be made. 
Future Work for Improvement 
of Risk Assessment and Protection
2007-01-3116
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